Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06246669 · ClinicalTrials.gov registry record · NA
The Influence of Prescribed Exercise on Pain Related Fear Following Concussion in Collegiate Athletes
A NA study of Concussion, Brain, sponsored by University of Virginia.
- Recruiting
- Registry status
- NA
- Development phase
- 46
- Enrollment target
- 1
- Study location
NCT06246669: Recruiting NA study of Concussion, Brain, sponsored by University of Virginia.
NCT06246669 is a NA study of Concussion, Brain that is actively recruiting participants, run by University of Virginia. The registered enrollment target is 46 participants, below the 182-participant average among 20 other Concussion, Brain trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06246669, a NA study of Concussion, Brain, is actively recruiting participants, sponsored by University of Virginia.
- RECRUITING
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to compare the effects of acute aerobic exercise at two different intensities on psychological measures, symptomology, and time to symptom free in collegiate student athletes with concussion. The main questions it aims to answer are: * Does prescribed, acute aerobic exercise influence measures of pain related fear, anxiety, depression, symptoms, and recovery time? * Does the intensity of the exercise prescription also influence the aforementioned outcomes? Participants will be randomly assigned into either a light intensity or moderate intensity aerobic exercise (treadmill walking) group. They will initiate the exercise protocol 48 hours following their concussion diagnosis, and complete exercise sessions 5 times per week until they report symptom-free. Researchers will compare the light intensity group to the moderate intensity group to see if intensity of exercise influences psychological measures of pain related fear, anxiety, depression, symptomology, and time to symptom-free.
Primary Outcome
A measure of fear beliefs associated with exercise, movement, and re-injury. Minimum score of 17, Maximum 68. Higher scores indicate worse kinesiophobia.
Conditions Studied
Interventions
- BEHAVIORAL Treadmill Walking
Study Locations (1)
Virginia
- University of Virginia Department of Kinesiology - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2024-02-27 |
| Est. Completion | 2025-03 |
| Phase | NA |
What NCT06246669 shows while recruiting
NCT06246669 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 182-participant average among 20 other Concussion, Brain trials with a reported enrollment target (75% lower).
The record links to 1 condition, with Concussion, Brain appearing as the primary indexed condition, and to 1 intervention - of which Treadmill Walking is the first listed.
NCT06246669 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT06246669 about?
NCT06246669 is a clinical study titled "The Influence of Prescribed Exercise on Pain Related Fear Following Concussion in Collegiate Athletes". The goal of this clinical trial is to compare the effects of acute aerobic exercise at two different intensities on psychological measures, symptomology, and time to symptom free in collegiate student athletes with concussion. The main questions it aims to answer are: * Does prescribed, acute aerob...
What is the current status of trial NCT06246669?
This trial is currently recruiting. It is a NA study. The enrollment target is 46 participants. The study started on 2024-02-27. Estimated completion is 2025-03.
What conditions does trial NCT06246669 study?
This clinical trial studies the following conditions: Concussion, Brain.
What interventions are being tested in trial NCT06246669?
The interventions under investigation include: Treadmill Walking (BEHAVIORAL).
Who is sponsoring clinical trial NCT06246669?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06246669 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Concussion, Brain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06246669's enrollment target sits among peer trials
46 18th of 20 higher than 3 of 20 other Concussion, Brain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Concussion, Brain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Combined Neuromodulation and Cognitive Training for Post-mTBI Depression
RECRUITING · NA
-
A Pragmatic Rehabilitation Intervention: The Active Rehab Study
RECRUITING · NA
-
CBT-I vs. MBTI for Traumatic Brain Injury (TBI)-Related Insomnia and Post-Traumatic Stress Symptoms
RECRUITING · NA
-
Creatine Supplementation in Concussion Recovery
RECRUITING · NA
-
Concussion Health Improvement Program
RECRUITING · NA
-
Mobile Subthreshold Exercise Program for Concussion--R01
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI